Company intelligence / Profile preview

Genolution

Ownership: Private
Development stage: Commercial

Overview

Genolution is a leading South Korean company specializing in the development and manufacture of automated nucleic acid extraction instruments, reagents for molecular diagnostics, genetic testing, life sciences research, and large-scale double-stranded RNA synthesis services. Their products are widely used in clinical laboratories, reference labs, academic institutions, government institutes, industry partners worldwide for molecular diagnostics and agricultural biotechnology applications. The company is publicly listed on KOSDAQ since July 2020.

Modalities: Nucleic acid extraction systemDouble-stranded RNA synthesis
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Genolution.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genolution.

Explore the full profile